SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
28.20
+0.30 (1.08%)
At close: Jun 4, 2025, 5:30 PM CET

ETR:1SXP Income Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Revenue
972.81957.09898.6821.14648.67584.23
Revenue Growth (YoY)
6.16%6.51%9.43%26.59%11.03%-
Cost of Revenue
652.74634.48582.11524.51422.5388.22
Gross Profit
320.07322.61316.49296.64226.17196.01
Selling, General & Admin
127.9125.18122.68110.7892.589.63
Research & Development
25.3624.2526.8223.5322.2923.58
Other Operating Expenses
-13.46-15.67-4.23-5.68-3.12-8.18
Operating Expenses
139.8133.77145.28128.63111.67105.04
Operating Income
180.27188.84171.21168.01114.590.97
Interest Expense
-16.95-12.78-6.66-2.11-1.19-1.51
Interest & Investment Income
8.195.965.232.140.560.56
Earnings From Equity Investments
13.9512.4911.7412.9913.75.55
Currency Exchange Gain (Loss)
1.82-11.092.71-7.03-1.450.45
Other Non Operating Income (Expenses)
-1.13-1.08-4.55-5.54-3.26-1.55
EBT Excluding Unusual Items
186.15182.35179.68168.46122.8794.46
Merger & Restructuring Charges
----11.78--
Gain (Loss) on Sale of Assets
0.590.590.391.510.30.72
Asset Writedown
--5.2---
Pretax Income
187.78183.97185.8158.29123.2895.3
Income Tax Expense
39.5733.6333.8732.4422.1217.67
Earnings From Continuing Operations
148.21150.35151.93125.85101.1777.63
Minority Interest in Earnings
-0.64-0.66-0.09-0.47-0.41-0.15
Net Income
147.57149.69151.84125.38100.7577.48
Net Income to Common
147.57149.69151.84125.38100.7577.48
Net Income Growth
9.61%-1.42%21.11%24.44%30.04%-
Shares Outstanding (Basic)
150151151151151151
Shares Outstanding (Diluted)
150151151151151151
Shares Change (YoY)
-0.96%-----
EPS (Basic)
0.980.991.010.830.670.51
EPS (Diluted)
0.980.991.010.830.670.51
EPS Growth
10.24%-1.80%21.46%24.08%31.17%-
Free Cash Flow
117.8880.256.1930.1134.1419.22
Free Cash Flow Per Share
0.790.530.040.200.230.13
Dividend Per Share
0.1600.1600.1500.125--
Dividend Growth
6.67%6.67%20.00%---
Gross Margin
32.90%33.71%35.22%36.13%34.87%33.55%
Operating Margin
18.53%19.73%19.05%20.46%17.65%15.57%
Profit Margin
15.17%15.64%16.90%15.27%15.53%13.26%
Free Cash Flow Margin
12.12%8.38%0.69%3.67%5.26%3.29%
EBITDA
247.58249217.5211.8150.94124.7
EBITDA Margin
25.45%26.02%24.20%25.79%23.27%21.34%
D&A For EBITDA
67.360.1646.2943.7936.4433.73
EBIT
180.27188.84171.21168.01114.590.97
EBIT Margin
18.53%19.73%19.05%20.46%17.65%15.57%
Effective Tax Rate
21.07%18.28%18.23%20.49%17.94%18.54%
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.